Legal
Key facts
Pomerantz LLP announced that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc
Key facts
Regeneron is identified as NASDAQ: REGN
Key facts
The case concerns whether Regeneron and certain officers and/or directors engaged in securities fraud or other…
Atlas Watchline
Pomerantz LLP said it filed a class action against Regeneron Pharmaceuticals and told investors with losses…